Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms

被引：23

作者：

de Almeida, Viviani ^{[1
]}

Engel, Daiane F. ^{[2
]}

Ricci, Mayra F. ^{[1
]}

Cruz, Clenio Silva ^{[1
]}

Lopes, Icaro Santos ^{[3
]}

Alves, Daniele Almeida ^{[4
]}

D' Auriol, Mirna ^{[5
]}

Magalhaes, Joao ^{[1
]}

Machado, Elayne C. ^{[1
]}

Rocha, Victor M. ^{[1
]}

Carvalho, Toniana G. ^{[6
]}

Lacerda, Larisse S. B. ^{[7
]}

Pimenta, Jordane C. ^{[7
]}

Aganetti, Mariana ^{[1
]}

Zuccoli, Giuliana S. ^{[8
]}

Smith, Bradley J. ^{[8
]}

Carregari, Victor C. ^{[8
]}

Rosa, Erika da Silva ^{[1
]}

Galvao, Izabela ^{[1
]}

Cassali, Geovanni Dantas ^{[9
]}

Garcia, Cristiana C. ^{[10
]}

Teixeira, Mauro Martins ^{[7
]}

Andre, Leiliane C. ^{[5
]}

Ribeiro, Fabiola Mara ^{[6
]}

Martins, Flaviano S. ^{[11
]}

Saia, Rafael Simone ^{[12
]}

Costa, Vivian Vasconcelos ^{[7
]}

Martins-de-Souza, Daniel ^{[8
,13
,14
,15
]}

Hansbro, Philip M. ^{[16
,17
]}

Marques, Joao Trindade ^{[4
,18
]}

Aguiar, Eric R. G. R. ^{[3
]}

Vieira, Angelica T. ^{[1
,19
]}

机构：

[1] Univ Fed Minas Gerais UFMG, Inst Biol Sci, Dept Biochem & Immunol, Lab Microbiota & Immunomodulat, Belo Horizonte, Brazil

[2] Univ Fed Ouro Preto UFOP, Sch Pharm, Dept Clin Anal, Ouro Preto, Brazil

[3] Univ Estadual Santa Cruz UESC, Ctr Biotechnol & Genet, Dept Biol Sci, Lab Virus Bioinformat, Ilheus, Brazil

[4] Univ Fed Minas Gerais UFMG, Inst Biol Sci, Dept Biochem & Immunol, Lab RNA Interference & Antiviral Immun, Belo Horizonte, Brazil

[5] Univ Fed Minas Gerais UFMG, Fac Pharm, Dept Clin & Toxicol Anal, Lab Toxicol, Belo Horizonte, Brazil

[6] Univ Fed Minas Gerais UFMG, Inst Biol Sci, Dept Biochem & Immunol, Lab Neurobiochem, Belo Horizonte, Brazil

[7] Univ Fed Minas Gerais UFMG, Inst Biol Sci, Ctr Res & Dev Drugs, Dept Morphol, Belo Horizonte, Brazil

[8] Univ Estado Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Lab Neuroproteom, Campinas, Brazil

[9] Univ Fed Minas Gerais UFMG, Dept Pathol, Lab Comparat Pathol, Belo Horizonte, Brazil

[10] Inst Oswaldo Cruz Fiocruz, Lab Resp Viruses & Measles, Rio de Janeiro, Brazil

[11] Univ Fed Minas Gerais UFMG, Inst Biol Sci, Dept Microbiol, Lab Biotherapeut Agents, Belo Horizonte, Brazil

[12] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Physiol, Lab Intestinal Physiol, Ribeirao Preto, Brazil

[13] DOR Inst Res & Educ, Sao Paulo, Brazil

[14] Univ Estado Campinas UNICAMP, Expt Med Res Cluster, Campinas, Brazil

[15] Natl Inst Biomarkers Neuropsychiat, Natl Council Sci & Technol Dev, Sao Paulo, Brazil

[16] Univ Technol Sydney, Centenary Inst, Ctr Inflammat, Sydney, Australia

[17] Univ Technol Sydney, Sydney, Australia

[18] Univ Strasbourg, CNRS UPR9022, Strasbourg, France

[19] Univ Fed Minas Gerais UFMG, Inst Biol Sci, Lab Microbiota & Immunomodulat, Av Pres Antonio Carlos,6627, Belo Horizonte, Brazil

来源：

GUT MICROBES | 2023年 / 15卷 / 02期

关键词：

COVID-19; SARS-CoV-2; post-COVID; microbiota; inflammation; antimicrobial-resistance; SARS-COV-2; RNA; INFECTION; MODEL; DISEASE; HUMANS;

D O I：

10.1080/19490976.2023.2249146

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Long-term sequelae of coronavirus disease (COVID)-19 are frequent and of major concern. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the host gut microbiota, which is linked to disease severity in patients with COVID-19. Here, we report that the gut microbiota of post-COVID subjects had a remarkable predominance of Enterobacteriaceae strains with an antibiotic-resistant phenotype compared to healthy controls. Additionally, short-chain fatty acid (SCFA) levels were reduced in feces. Fecal transplantation from post-COVID subjects to germ-free mice led to lung inflammation and worse outcomes during pulmonary infection by multidrug-resistant Klebsiella pneumoniae. transplanted mice also exhibited poor cognitive performance. Overall, we show prolonged impacts of SARS-CoV-2 infection on the gut microbiota that persist after subjects have cleared the virus. Together, these data demonstrate that the gut microbiota can directly contribute to post-COVID sequelae, suggesting that it may be a potential therapeutic target.

引用

页数：22

共 50 条

[1] Post-COVID symptoms and recovery times in hospitalized mild and moderate COVID-19 patients
Khot, Rajashree
Patil, Aastha
Rathod, Bharatsing
Kumbhalkar, Sunita D.
Joshi, Prashant P.
INTERNATIONAL JOURNAL OF ACADEMIC MEDICINE, 2023, 9 (02) : 39 - 46
[2] Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
Zuo, Tao
Zhang, Fen
Lui, Grace C. Y.
Yeoh, Yun Kit
Li, Amy Y. L.
Zhan, Hui
Wan, Yating
Chung, Arthur C. K.
Cheung, Chun Pan
Chen, Nan
Lai, Christopher K. C.
Chen, Zigui
Tso, Eugene Y. K.
Fung, Kitty S. C.
Chan, Veronica
Ling, Lowell
Joynt, Gavin
Hui, David S. C.
Chan, Francis K. L.
Chan, Paul K. S.
Ng, Siew C.
GASTROENTEROLOGY, 2020, 159 (03) : 944 - +
[3] Autoantibodies in COVID-19 survivors with post-COVID symptoms: a systematic review
Notarte, Kin Israel
Carandang, Timothy Hudson David Culasino
Velasco, Jacqueline Veronica
Pastrana, Adriel
Ver, Abbygail Therese
Manalo, Gerald Neil
Ng, Jeremy Ace
Grecia, Steven
Lippi, Giuseppe
Henry, Brandon Michael
Fernandez-de-las-Penas, Cesar
FRONTIERS IN IMMUNOLOGY, 2024, 15
[4] COVID-19, POST-COVID AND FRAILTY
Dionyssiotis, Y.
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S98 - S98
[5] Post-COVID Conditions in Hospitalized COVID-19 Patients in Germany
Pacis, S.
Maywald, U.
Wilke, T.
Ghiani, M.
VALUE IN HEALTH, 2022, 25 (12) : S197 - S198
[6] Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated
Abdelhafiz, Ahmed Samir
Ali, Asmaa
Maaly, Ayman Mohamed
Mahgoub, Mohamed Anwar
Ziady, Hany Hassan
Sultan, Eman Anwar
PLOS ONE, 2022, 17 (03):
[7] The gut microbiota in patients with COVID-19 and obesity
Massip Copiz, Maria Macarena
FASEB JOURNAL, 2021, 35
[8] Autoimmunity, COVID-19, Post-COVID 19 Syndrome and COVID-19 Vaccination
Ashkenazi, S.
Shoenfeld, Yehuda
Dotan, Arad
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2023, 25 (02): : 161 - 162
[9] Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity
Maeda, Yuichi
Motooka, Daisuke
Kawasaki, Takahiro
Oki, Hiroya
Noda, Yoshimi
Adachi, Yuichi
Niitsu, Takayuki
Okamoto, Shota
Tanaka, Kentaro
Fukushima, Kiyoharu
Amiya, Saori
Hara, Reina
Oguro-Igashira, Eri
Matsuki, Takanori
Hirata, Haruhiko
Takeda, Yoshito
Kida, Hiroshi
Kumanogoh, Atsushi
Nakamura, Shota
Takeda, Kiyoshi
BMC INFECTIOUS DISEASES, 2022, 22 (01)
[10] Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity
Yuichi Maeda
Daisuke Motooka
Takahiro Kawasaki
Hiroya Oki
Yoshimi Noda
Yuichi Adachi
Takayuki Niitsu
Shota Okamoto
Kentaro Tanaka
Kiyoharu Fukushima
Saori Amiya
Reina Hara
Eri Oguro-Igashira
Takanori Matsuki
Haruhiko Hirata
Yoshito Takeda
Hiroshi Kida
Atsushi Kumanogoh
Shota Nakamura
Kiyoshi Takeda
BMC Infectious Diseases, 22

← 1 2 3 4 5 →